Status:
COMPLETED
COVID-19 on Disease Activity in Radiologically Isolated Syndrome Cohort
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Multiple Sclerosis
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
The Radiologically Isolated Syndrome (RIS) is defined as incidental Magnetic Resonance Imaging (MRI) abnormalities fulfil the criteria for dissemination in space, suggestive of multiple sclerosis. Now...
Eligibility Criteria
Inclusion
- patients belong to the RISC cohort;
- totally vaccinated ou partially vaccinated patient
- vaccination status known
Exclusion
- presented a first clinical event before the COVID19 vaccination
Key Trial Info
Start Date :
May 31 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
217 Patients enrolled
Trial Details
Trial ID
NCT05387395
Start Date
May 31 2022
End Date
July 1 2022
Last Update
August 1 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nice University Hospital
Nice, France, 06000